Hepatoblastoma in a 14-months old child

Authors

  • Rashes Shrestha Thoracic Surgery Unit, Dept of surgical oncology, BP Koirala Memorial Cancer Hospital
  • Niraj Bhattarai Thoracic Surgery Unit, Dept of surgical oncology, BP Koirala Memorial Cancer Hospital, Nepal
  • Binay Thakur Thoracic Surgery Unit, Dept of surgical oncology, BP Koirala Memorial Cancer Hospital, Nepal
  • Mukti Devkota Thoracic Surgery Unit, Dept of surgical oncology, BP Koirala Memorial Cancer Hospital, Nepal
  • Rajesh Kumar Mandel Thoracic Surgery Unit, Dept of surgical oncology, BP Koirala Memorial Cancer Hospital, Nepal
  • Purushottam Adhikari Thoracic Surgery Unit, Dept of surgical oncology, BP Koirala Memorial Cancer Hospital, Nepal

DOI:

https://doi.org/10.3126/njc.v5i1.41366

Keywords:

chemotherapy, hepatoblastoma, liver resection

Abstract

In children, commonest liver tumor is hepatoblastoma. We present a 14-month-old male child who presented with abdominal distension and loose stool. Radiological imaging revealed solid hepatic mass. Hematological investigations revealed anemia, thrombocytosis and high Serum alpha fetoprotein (AFP) level. Ultrasound (USG) guided FNAC confirmed the mass to be hepatoblastoma. CT scan revealed hepatoblastoma PRETEXT stage III. The patient underwent 6 cycles of neoadjuvant chemotherapy and responded to POSTTEXT stage II. Left hemi-hepatectomy was done with clear resectin margins. Complete surgical excision of the mass after preoperative chemotherapy remains the mainstay of the treatment of locally advanced hepatoblastoma. 

Downloads

Download data is not yet available.
Abstract
79
PDF
97

Downloads

Published

2021-09-26

How to Cite

Shrestha, R. ., Bhattarai, N., Thakur, B., Devkota, M., Mandel, R. K., & Adhikari, P. (2021). Hepatoblastoma in a 14-months old child. Nepalese Journal of Cancer, 5(1), 80–82. https://doi.org/10.3126/njc.v5i1.41366

Issue

Vol. 5 No. 1 (2021)

Section

Case Reports

License

Copyright (c) 2021 Nepalese Journal of Cancer

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

This license lets others distribute, remix, tweak, and build upon your work, even commercially, as long as NJC and the authors are acknowledged.

Submission of the manuscript means that the authors agree to assign exclusive copyright to NJC. The aim of NJC is to increase the visibility and ease of use of open access scientific and scholarly articles thereby promoting their increased usage and impact.